APO Research

APO RESEARCH · REPORT

Contrast Agents

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

Product & engineering

Understand the product.

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

Selected research

Market Structure

Global Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

Global Contrast Agents key players include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, etc. Global top four manufacturers hold a share over 75%.

Asia-Pacific is the largest market, with a share over 40%, followed by Europe, and North America, both have a share over 50 percent.

Read the full market overview

In terms of product, X-ray and CT is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospitals, followed by Clinics.

This report provides an overview of the global Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Contrast Agents Segment by Company

GE Healthcare

Bayer

Bracco Imaging

Guerbet Group

Hengrui Medicine

Lantheus

YRPG

BeiLu Pharma

Contrast Agents Segment by Type

X-ray and CT

MRI

Ultrasound

Contrast Agents Segment by Application

Hospitals

Clinics

Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contrast Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Contrast Agents Industry Trends Table 2. Contrast Agents Industry Drivers Table 3. Contrast Agents Industry Opportunities and Challenges Table 4. Contrast Agents Industry Restraints Table 5. Global Contrast Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Contrast Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Contrast Agents Sales by Manufacturers (K Dose) & (2021-2026) Table 8. Global Contrast Agents Sales Market Share by Manufacturers Table 9. Global Contrast Agents Average Sales Price (USD/Dose) of Manufacturers (2021-2026) Table 10. Global Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Contrast Agents Manufacturers, Product Type & Application Table 13. Global Contrast Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of X-ray and CT Table 17. Major Manufacturers of MRI Table 18. Major Manufacturers of Ultrasound Table 19. Global Contrast Agents Sales by Type 2021 VS 2025 VS 2032 (K Dose) Table 20. Global Contrast Agents Sales by Type (2021-2026) & (K Dose) Table 21. Global Contrast Agents Sales by Type (2027-2032) & (K Dose) Table 22. Global Contrast Agents Sales Market Share by Type (2021-2026) Table 23. Global Contrast Agents Sales Market Share by Type (2027-2032) Table 24. Global Contrast Agents Revenue by Type 2021 VS 2025 VS 2032 (K Dose) Table 25. Global Contrast Agents Revenue by Type (2021-2026) & (K Dose) Table 26. Global Contrast Agents Revenue by Type (2027-2032) & (K Dose) Table 27. Global Contrast Agents Revenue Market Share by Type (2021-2026) Table 28. Global Contrast Agents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Global Contrast Agents Sales by Application 2021 VS 2025 VS 2032 (K Dose) Table 32. Global Contrast Agents Sales by Application (2021-2026) & (K Dose) Table 33. Global Contrast Agents Sales by Application (2027-2032) & (K Dose) Table 34. Global Contrast Agents Sales Market Share by Application (2021-2026) Table 35. Global Contrast Agents Sales Market Share by Application (2027-2032) Table 36. Global Contrast Agents Revenue by Application 2021 VS 2025 VS 2032 (K Dose) Table 37. Global Contrast Agents Revenue by Application (2021-2026) & (K Dose) Table 38. Global Contrast Agents Revenue by Application (2027-2032) & (K Dose) Table 39. Global Contrast Agents Revenue Market Share by Application (2021-2026) Table 40. Global Contrast Agents Revenue Market Share by Application (2027-2032) Table 41. Global Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Table 42. Global Contrast Agents Sales by Region (2021-2026) & (K Dose) Table 43. Global Contrast Agents Sales Market Share by Region (2021-2026) Table 44. Global Contrast Agents Sales Forecasted by Region (2027-2032) & (K Dose) Table 45. Global Contrast Agents Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 47. North America Contrast Agents Sales by Country (2021-2026) & (K Dose) Table 48. North America Contrast Agents Sales by Country (2027-2032) & (K Dose) Table 49. Europe Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 50. Europe Contrast Agents Sales by Country (2021-2026) & (K Dose) Table 51. Europe Contrast Agents Sales by Country (2027-2032) & (K Dose) Table 52. Asia Pacific Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 53. Asia Pacific Contrast Agents Sales by Country (2021-2026) & (K Dose) Table 54. Asia Pacific Contrast Agents Sales by Country (2027-2032) & (K Dose) Table 55. South America, Middle East and Africa Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 56. South America, Middle East and Africa Contrast Agents Sales by Country (2021-2026) & (K Dose) Table 57. South America, Middle East and Africa Contrast Agents Sales by Country (2027-2032) & (K Dose) Table 58. Global Contrast Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Contrast Agents Revenue Market Share by Region (2021-2026) Table 62. Global Contrast Agents Revenue Market Share by Region (2027-2032) Table 63. GE Healthcare Company Information Table 64. GE Healthcare Business Overview Table 65. GE Healthcare Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GE Healthcare Contrast Agents Product Portfolio Table 67. GE Healthcare Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bayer Contrast Agents Product Portfolio Table 72. Bayer Recent Development Table 73. Bracco Imaging Company Information Table 74. Bracco Imaging Business Overview Table 75. Bracco Imaging Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bracco Imaging Contrast Agents Product Portfolio Table 77. Bracco Imaging Recent Development Table 78. Guerbet Group Company Information Table 79. Guerbet Group Business Overview Table 80. Guerbet Group Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Guerbet Group Contrast Agents Product Portfolio Table 82. Guerbet Group Recent Development Table 83. Hengrui Medicine Company Information Table 84. Hengrui Medicine Business Overview Table 85. Hengrui Medicine Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hengrui Medicine Contrast Agents Product Portfolio Table 87. Hengrui Medicine Recent Development Table 88. Lantheus Company Information Table 89. Lantheus Business Overview Table 90. Lantheus Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lantheus Contrast Agents Product Portfolio Table 92. Lantheus Recent Development Table 93. YRPG Company Information Table 94. YRPG Business Overview Table 95. YRPG Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. YRPG Contrast Agents Product Portfolio Table 97. YRPG Recent Development Table 98. BeiLu Pharma Company Information Table 99. BeiLu Pharma Business Overview Table 100. BeiLu Pharma Contrast Agents Sales (K Dose), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. BeiLu Pharma Contrast Agents Product Portfolio Table 102. BeiLu Pharma Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Contrast Agents Distributors List Table 106. Contrast Agents Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Contrast Agents Product Image Figure 2. Global Contrast Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Contrast Agents Sales (2021-2032) & (K Dose) Figure 5. Global Contrast Agents Average Price (USD/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Contrast Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. X-ray and CT Image Figure 9. MRI Image Figure 10. Ultrasound Image Figure 11. Global Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 12. Global Contrast Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Contrast Agents Sales Market Share by Type (2021-2032) Figure 14. Global Contrast Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 15. Global Contrast Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Contrast Agents Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Global Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 20. Global Contrast Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Contrast Agents Sales Market Share by Application (2021-2032) Figure 22. Global Contrast Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 23. Global Contrast Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Contrast Agents Revenue Market Share by Application (2021-2032) Figure 25. North America Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 26. North America Contrast Agents Sales Market Share by Country (2021-2032) Figure 27. U.S. Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 28. Canada Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 29. Mexico Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 30. Europe Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 31. Europe Contrast Agents Sales Market Share by Country (2021-2032) Figure 32. Germany Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 33. France Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 34. U.K. Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 35. Italy Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 36. Netherlands Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 37. Asia Pacific Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 38. Asia Pacific Contrast Agents Sales Market Share by Country (2021-2032) Figure 39. China Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 40. Japan Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 41. South Korea Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 42. Southeast Asia Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 43. India Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 44. Australia Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 45. South America, Middle East and Africa Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 46. South America, Middle East and Africa Contrast Agents Sales Market Share by Country (2021-2032) Figure 47. Brazil Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 48. South Africa Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 49. Saudi Arabia Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 50. Turkey Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 51. Argentina Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 52. UAE Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 53. Egypt Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 54. Chile Contrast Agents Sales and Growth Rate (2021-2032) & (K Dose) Figure 55. Global Contrast Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Contrast Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 58. North America Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 60. Europe Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Contrast Agents Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Contrast Agents Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • X-ray and CT
  • MRI
  • Ultrasound
Applications
  • Hospitals
  • Clinics
Companies covered
  • GE Healthcare
  • Bayer
  • Bracco Imaging
  • Guerbet Group
  • Hengrui Medicine
  • Lantheus
  • YRPG
  • BeiLu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contrast Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contrast Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Contrast Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Contrast Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Contrast Agents Market Dynamics
  1. 2.1 Contrast Agents Industry Trends
  2. 2.2 Contrast Agents Industry Drivers
  3. 2.3 Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Contrast Agents Industry Restraints
3 Contrast Agents Market by Manufacturers
  1. 3.1 Global Contrast Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Contrast Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Contrast Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Contrast Agents Manufacturers, Product Type & Application
  7. 3.7 Global Contrast Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contrast Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contrast Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contrast Agents Tier 1, Tier 2, and Tier 3
4 Contrast Agents Market by Type
  1. 4.1 Contrast Agents Type Introduction
  2. 4.1.1 X-ray and CT
  3. 4.1.2 MRI
  4. 4.1.3 Ultrasound
  5. 4.2 Global Contrast Agents Sales by Type
  6. 4.2.1 Global Contrast Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Contrast Agents Sales by Type (2021-2032)
  8. 4.2.3 Global Contrast Agents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Contrast Agents Revenue by Type
  10. 4.3.1 Global Contrast Agents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Contrast Agents Revenue by Type (2021-2032)
  12. 4.3.3 Global Contrast Agents Revenue Market Share by Type (2021-2032)
5 Contrast Agents Market by Application
  1. 5.1 Contrast Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Contrast Agents Sales by Application
  5. 5.2.1 Global Contrast Agents Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contrast Agents Sales by Application (2021-2032)
  7. 5.2.3 Global Contrast Agents Sales Market Share by Application (2021-2032)
  8. 5.3 Global Contrast Agents Revenue by Application
  9. 5.3.1 Global Contrast Agents Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Contrast Agents Revenue by Application (2021-2032)
  11. 5.3.3 Global Contrast Agents Revenue Market Share by Application (2021-2032)
6 Global Contrast Agents Sales by Region
  1. 6.1 Global Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Contrast Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Contrast Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Contrast Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Contrast Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Contrast Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Contrast Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Contrast Agents Revenue by Region
  1. 7.1 Global Contrast Agents Revenue by Region
  2. 7.1.1 Global Contrast Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Contrast Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Contrast Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Contrast Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Contrast Agents Revenue (2021-2032)
  8. 7.2.2 North America Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Contrast Agents Revenue (2021-2032)
  11. 7.3.2 Europe Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Contrast Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Contrast Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GE Healthcare
  2. 8.1.1 GE Healthcare Company Information
  3. 8.1.2 GE Healthcare Business Overview
  4. 8.1.3 GE Healthcare Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GE Healthcare Contrast Agents Product Portfolio
  6. 8.1.5 GE Healthcare Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Contrast Agents Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Bracco Imaging
  14. 8.3.1 Bracco Imaging Company Information
  15. 8.3.2 Bracco Imaging Business Overview
  16. 8.3.3 Bracco Imaging Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bracco Imaging Contrast Agents Product Portfolio
  18. 8.3.5 Bracco Imaging Recent Developments
  19. 8.4 Guerbet Group
  20. 8.4.1 Guerbet Group Company Information
  21. 8.4.2 Guerbet Group Business Overview
  22. 8.4.3 Guerbet Group Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guerbet Group Contrast Agents Product Portfolio
  24. 8.4.5 Guerbet Group Recent Developments
  25. 8.5 Hengrui Medicine
  26. 8.5.1 Hengrui Medicine Company Information
  27. 8.5.2 Hengrui Medicine Business Overview
  28. 8.5.3 Hengrui Medicine Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hengrui Medicine Contrast Agents Product Portfolio
  30. 8.5.5 Hengrui Medicine Recent Developments
  31. 8.6 Lantheus
  32. 8.6.1 Lantheus Company Information
  33. 8.6.2 Lantheus Business Overview
  34. 8.6.3 Lantheus Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lantheus Contrast Agents Product Portfolio
  36. 8.6.5 Lantheus Recent Developments
  37. 8.7 YRPG
  38. 8.7.1 YRPG Company Information
  39. 8.7.2 YRPG Business Overview
  40. 8.7.3 YRPG Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 YRPG Contrast Agents Product Portfolio
  42. 8.7.5 YRPG Recent Developments
  43. 8.8 BeiLu Pharma
  44. 8.8.1 BeiLu Pharma Company Information
  45. 8.8.2 BeiLu Pharma Business Overview
  46. 8.8.3 BeiLu Pharma Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BeiLu Pharma Contrast Agents Product Portfolio
  48. 8.8.5 BeiLu Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contrast Agents Value Chain Analysis
  2. 9.1.1 Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contrast Agents Production Mode & Process
  6. 9.2 Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contrast Agents Distributors
  9. 9.2.3 Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research